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The Global use of micronutrients in health care delivery has taken center stage due to the realization of 
their importance in disease management. Sickle cell disease, malaria and diabetes are among the 
diseases plaguing a good population of the developing world and the cost implication for their 
management is very high. Sickle cell disease and malaria have anemia as a common factor and 
immunological disturbances are also prevalent in these disease conditions. Free radicals are generated 
in sickle cell disease, malaria and diabetes so a balance between minerals and antioxidants is 
imperative to maintain membrane integrity and function. Protection of red cell membranes from free 
radical-mediated oxidative stress is crucial to their management. Minerals such as copper, iron, 
chromium, magnesium, selenium and vanadium as well as vitamins like A, C, E, folate and the B group 
have been found to relieve oxidative stress associated with them. Micronutrients and their importance 
in the management of sickle cell disease, malaria and diabetes is reviewed here, with emphasis on the 
need to harness the natural resources abundant in our environment.  
 





Agriculture provides the entire nutrient requirement to 
sustain life on earth. The farming systems of developing 
world cannot meet the nutritional needs of their people. 
Therefore, it is important to establish a relationship 
between agriculture, nutrition and health to find 
sustainable solutions to nutrient malnutrition (Welch and 
Graham, 2005). 
Micronutrients consist of vitamins and minerals 
required by the body in small quantities for the normal 
function of cellular metabolic processes. They usually 
function as essential cofactors in the numerous enzyme 
catalyzed reactions and their absence can result in 
impairment of metabolic functions which can lead to 
serious disease conditions. Currently, attention is focused 
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heart disease, cancer, osteoporosis and other chronic 
and degenerative diseases such as diabetes, Parkinson’s  
and Alzmeimer’s ( Hypponen, 2004; Mandel, 2005).  
Sickle cell disease, malaria and diabetes are common 
diseases which plague our communities in Africa and 
deserve cooperation from both medical practitioners and 
scientists in related areas to identify rational and 
sustainable strategies to manage these conditions 
effectively. Sickle cell is a heritable disease for which no 
cure has yet been found. Very often in our midst, we 
sadly experience the tremendous suffering and 
helplessness of parents managing children who have 
sickle cell disease (SCD). Children with SCD are 
characteristically thin, stunted in growth, pale because of 
chronic hemolysis and cell death, poor fat muscle and 
bone mass. These characteristics are associated with 
increased energy demand. The red blood cell (RBC) 
membrane’s integrity is maintained by its hydration. If the 
membrane becomes dehydrated, this impacts on its 





sickled, they clog the small blood vessels so that the 
tissues are deprived  of  oxygen  
and other nutrients, this leads to oxidative stress and 
derangement of tissue functions. Anemia is caused by 
fragile red cell membranes which induce premature 
destruction of red blood cell and sickle cell crises may be 
caused by blood vessel occlusion triggered by membrane 
deformation (Ohnishi and Ogunmola, 1999; Ohnishi et 
al., 2000). It is pertinent to note that after so many years 
since the discovery that the sickle cell hemoglobin had 
abnormal eletrophoretic mobility, no substantial research 
work has been undertaken to understand the 
mechanisms of the disease (Bunn, 1997). 
Presently the healthcare cost in the management of 
patients with sickle cell disease is disproportionately high 
compared with the number of people afflicted by the 
disease. The group most affected by this high cost is the 
common people in our localities who belong to the low 
socio-economic class. Therefore, the use of herbal 
mixtures and supplements has been on the increase in 
the management of sickle cell disease (Ajayi et al., 1993; 
Ballas , 2000; Wambebe et al., 2001).  
It is a known fact that Malaria is the most important 
parasitic disease infecting people in vast areas of Africa 
and beyond (Greenwood et al., 2005). The causative 
agent and the mode of transmission are clearly 
understood. The devastating effects of malaria is 
reflected in the estimates suggesting that it directly 
causes about one million deaths per year or 3000 deaths 
per day, most of these deaths occur in African children ( 
Greenwood et al., 2005). Recently, an initiative such as 
Roll Back Malaria Partnership scheme has come on 
board to check the increasing afflictions due to Malaria. In 
spite of the fact that this is a laudable programme, it is 
not cost effective for the rural communities who are 
supposed to be the important beneficiaries of the 
scheme. Malaria is a re-emerging disease due to drug 
resistance which can be as a result of gene mutations 
caused by the abuse of the over-the-counter drugs, 
compliance failure, fake and adulterated products. A 
common important feature of malaria is severe anemia 
that causes death in areas with intense malaria 
transmission. Currently modern pharmaceuticals are too 
expensive in areas where malaria is endemic therefore 
the use of herbal remedies is popular. 
Diabetes is a complex non communicable disease 
characterized by elevated level of glucose in the blood 
and urine. Secretion of glucose in urine occurs when the 
blood glucose level exceeds the kidney threshold. Many 
factors contribute to the manifestations of clinical features 
described as diabetes. These include hormonal 
influences, genetic and many kinds of underlying 
molecular defects as well as components of dietary and 
environmental origin. It is classified as Type I or Type II 
depending on whether it is insulin dependent or non-
insulin dependent. Type I is known as insulin-dependent 
diabetes  (IDDM).  People  who  suffer from  this   type  of  




diabetes require regular injection of insulin to maintain life 
and limit  the  development  of  complications.  Type  II  is  
non-insulin dependent diabetes (NIDDM). This subclass 
is heterogenous, with genetic, nutritional and 
environmental factors contributing to the deterioration of 
carbohydrate tolerance. The loss of water and glucose 
which occur in diabetes leads to many metabolic changes 
such as fat and protein breakdown as well as the 
consequent generation of ketone bodies. But these do 
not constitute the focus of our discussion in this review 
and will not be considered further. 
We are concerned by the fact that diabetes is quietly 
taking its toll on many individuals among our populace, 
yet it does not seem to attract any significant attention as 
is the case with malaria or HIV/AIDS or even the sickle 
cell disease. We are alarmed by the number of people 
who approach us with inquiries about the use of natural 
products to take care of their diabetic problems. That has 
informed us to include this topic in this discussion. 
Each of the three diseases has its unique cause or 
origin. Malaria is of parasitic origin, sickle cell disease is 
genetic, while diabetes originates from both genetic and 
metabolic sources as already discussed. In spite of this, 
they all, in their respective clinical presentations point to 
some common consequences –anemia which is common 
to the sickle cell disease and malaria, generation of free 
radicals in excess of what obtains under normal 
physiological conditions and weakening of the immune 
defense mechanism. In addition, the metabolic interplay 
that accompany the manifestation of these clinical 
features, result in the depletion of certain nutrient and 
micronutrients needed in the respective metabolic 
processes. There is no doubt that nutritional status 
influences susceptibility and immunity to various 
infectious and non-infectious diseases. 
In this review, we wish to look at recent developments 
in the management of sickle cell disease, malaria and 
diabetes using micronutrients. We are interested in 
micronutrients because of the experiences from our 
research activities with natural products. We are 
convinced that with enlightenment, the debilitating effects 
of these aliments can be comfortably managed in the 
ordinary home setting. We are aware that herbs and 
medicinal plants are a reservoir of these essential and 
beneficial nutrient components. Our objectives are: 
 
a. To identify micronutrients that have been found 
essential in the respective disease conditions and 
examine the extent to which they have been useful in the 
management of each case. 
b. To explore the metabolic functions they carry out, 
which alleviate the applicable disease state. 
c. Gather information and document sources of these 
micronutrients for the benefit of the generality of our 
society as a means of pointing out the need for more 
research into this important area that has received little 
attention,  at  least,  in  the  sub-Saharan  African  region. 








SICKLE CELL DISEASE (SCD) 
 
Many metabolic changes which occur in SCD that lead to 
anemia include sickling, generation of reactive oxygen 
species and the general decrease in the rate of physical 
development. Anemia is a life threathening feature in  
SCD. There is increased  turnover of hemopoietic cells 
due to chronic hemolysis and cell death leading to 
tremendous red marrow expansion. These conditions 
lead to hyper-metabolic rate and increases in nutrient and 
energy demand (Malik, 1999). Nutrient deficiency, red 
cell dehydration, cell fragility which induce premature 




Use of   micronutrients in the management of anemia 
in SCD 
 
Maintaining the membrane integrity is the bottom line in 
the control of anemia in SCD. Disruption of membrane 
integrity arises from fragility, dehydration as well as 
increased production of reactive oxygen species. Chronic 
hemolysis lead to loss of hemoglobin. These metabolic 
changes lead to depletion of essential nutrients and 
micronutrients required for proper cell function.  
Some minerals and vitamins have been found 
beneficial in the control of anemia under this condition. 
These include iron (Fe), copper (Cu), zinc (Zn) and folate 
(Prasad, 1999). Prasad et al. (1975) first reported zinc 
deficiency in adult patients with sickle cell disease. Iron is 
very important in the synthesis of hemoglobin and Cu and 
Zn play very important roles in Fe metabolism (Prasad, 
1999). The biological importance of iron in mammals is 
well known. Therefore its importance in this situation of 
loss of hemoglobin cannot be over emphasized 
considering its role in oxygen transport as well as in 
many metalloenzymes involved in oxidative 
phosphorylation. 
Copper is known to be essential in the proper 
functioning of different metalloenzymes which include 
ceruloplasmin involved in iron metabolism. Deficiency of 
copper is known to cause anemia. The mechanism of 
copper deficiency-induced anemia is not understood 
(Das, 1990). Previous studies suggest that the copper-
containing enzyme, ceruloplasmin, may have specific 
role, probably related to its function in mobilization of 
stored iron in the liver which makes iron available for 
hemoglobin synthesis (Das, 1990). However, it has been 
observed that in copper deficiency-induced anemia, in 
spite of elevated iron level in the liver, the rate of 
hemoglobin synthesis remains significantly reduced (Das, 
1990). 
Like copper, the mechanism through which zinc exerts 
its effect in correcting anemia in SCD is not understood, 
but it is known that the proteins making up the 
cytoskeleton of cell membranes acquire  some  abnormal 
configurations and often get irreversibly damaged. Zinc 
prevents the formation of such irreversibly damaged 
sickle cells (Das, 1990). Furthermore, it has been 
proposed that the role of zinc in the management of 
sickle cell anemia centers on its calcium antagonism. 
Zinc is known to inhibit the activity of calmodulin which  
activates the calcium-ATPase that controls the calcium 
pump system of the erythrocytes. During sickling, there is 
an influx of calcium into the erythrocytes and this occurs, 
probably, due to the fact that the calmodulin is so over-
activated that the membrane is destroyed. It is 
suggested, therefore, that during zinc therapy, its anti-
calcium action, (through its effect on calmodulin) 
produces anti-sickling effect (Das, 1990).                                           
 
 
Sickling and free radical generation in SCD 
 
The erythrocyte from individuals with SCD are fewer in 
number than normal and are abnormal. When 
hemoglobin from sickle cells is deoxygenated, it becomes 
insoluble and forms polymers that aggregate into tubular 
fibers. The insoluble fibers are responsible for the 
deformed sickle shape of the erythrocytes. These block 
the blood capillaries causing severe pain and interference 
with organ function. Also the red blood cell membrane 
integrity is maintained by its hydration, but in SCD the 
cells are dehydrated and this impacts on its deformability 
which may lead to sickling. Red cells generate super 
oxide species (which are also generally generated under 
normal physiological conditions) but which are drastically 
increased in SCD. Unstable hemoglobin produced under 
this condition generates free radicals which are more 




Micronutients in the control of sickling and reactive 
oxygen generation in SCD  
 
The sickle erythrocytes are fragile and dehydrated. They 
require a delicate balance of minerals and antioxidants to 
maintain hydration and membrane integrity (Malik, 1999). 
It has been shown that Magnesium (Mg) is effective in 
reducing not only the painful episode in SCD but also 
affects the hydration of RBC. Brugnara (1999) has 
reported that K-Cl cotransport is a major determinant in 
the dehydration of erythrocytes in SCD. Reduced 
erythrocyte-magnesium content with normal serum Mg is 
observed as a common feature of HbSS in sickle cell 
disease. When the internal Mg of the erythrocytes is 
increased, the activity of K-Cl  cotransport  is markedly 
diminished. Therefore, blockage of this pathway by 
intracellular Mg could result in decreased dehydration 
and sickling in vivo (Brugnara, 1999). Among the many 
important functions of Mg is its involvement, along with 









are known to act as bridges between the neighbouring 
carboxylate groups in lipoproteins and such bridges 
stiffen the cell membranes (Das, 1990). 
The generation of reactive oxygen species which is a 
steady state cellular event in normal respiring cells, is 
exacerbated in sickle cell disease as in many other  
diseases. Uncontrolled production of reactive oxygen 
often leads to damage of cellular macromolecules such 
as lipids, proteins and DNA as well as other antioxidant 
molecules (Chan, 1999). Protection of red cell 
membranes from free radical-mediated oxidative stress is 
crucial to the successful management of the sickle cell 
crisis. Certain minerals, copper, iron, magnesium 
selenium as well as some antioxidants and vitamins, 
have been found to effectively relieve the oxidative stress 
that prevails in SCD. The vitamins include vitamins C, E, 
folate, vitamin B12 and B6 (Nalta et al., 1980; Whethers, 
1999; Sies et al., 2005). Other nutrients include 
tryptophan, lipoic acid and carotenoids (Chan, 1999). 
Ohnishi and Ohnishi (2001) proposed that a cocktail of 
antioxidants would be effective in alleviating the 
incidence and severity of crisis in sickle cell patients. 
In sickle cell anemia, these micronutrients are deficient. 
Some of them act as cofactors for the enzyme systems 
involved in reactive oxygen removal. For example, 
selenium is a prosthetic group of a metalloenzyme, the 
glutathione peroxidase which functions in the protection 
of hemoglobin. Copper, iron and magnesium have been 
discussed earlier in terms of their roles in hemoglobin 
synthesis. Besides, copper is a prosthetic group in 
ascorbate oxidase which is involved in the oxidation of 
ascorbic acid-an antioxidant, ceruloplasmin involved in 
iron metabolism as well as superoxide dismutase. Some 
animal studies have indicated that the limiting feature of 
zinc is associated with the post-translational change in 
plasma membrane proteins. Red cells from zinc-deficient 
rats showed increased osmotic fragility associated with 
decreased plasma membrane sulfhydryl concentration 
and this is readily reversed by dietary zinc 
supplementation (O’ Dell, 2000). Further discussions on 




General physical development and immune system 
function are diminished in SCD 
 
The diminished growth deficits in children with 
homozygous sickle cell disease, including low weight, 
reduced height velocity for age, delayed skeletal and 
sexual maturation and reduced fat deposits are 
consistent with suboptimal nutrition (Singhal, 1999). 
Factors that would contribute to these conditions include 
metabolic demands of an expanded bone marrow as well 
as high energy expenditure and a relatively low energy 
intake. According to Singhal (1999), the resting metabolic 
rate appears  to  be  16-20%  greater  in  SS  adolescents  
than in control subjects. Poor food availability (especially 
in developing countries) or appetite depression 
associated with a chronic low grade inflammatory 




Micronutrients in the improvement of physical 
development and immune system in SCD 
 
Zinc is known as an important nutrient for growth and 
development. Its effects are evident in children with sickle 
cell disease, where it affects growth, sexual maturation 
and immune function (Zemel et al., 2002). A deficiency of 
zinc in patients with sickle cell disease results in growth 
retardation (dwarfism), hypogonadism in males, rough 
skin, poor appetite, mental lethargy and recurrent 
infections. Interleukin-2 activity is tremendously 
decreased if Zn is deficient. The addition of Zn will 
increase the production of interleukin-2. The amount of 
interleukin-1B, a cytotoxic cytokinine, increases if there is 
a deficiency in zinc (Prasad, 1999). Zinc serves as 
coenzyme in very many enzymes which include 
transcriptases, some pyrimidine nucleotide dehydroge-
nases, DNA polymerase and plays many fundamental 
roles in cell replication, gene expression and in the 
metabolism of nucleic acids and proteins. Zinc is also 
essential in the spermatogenic cycle and at the stage of 
maturation of spermatids to form spermatozoa (Das, 
1990). 
Chromium is another mineral that has been found 
beneficial in the management of sickle cell disease. The 
involvement of chromium in SCD is not clearly defined 
but it is known that it potentiates insulin action. It has 
been proposed that chromium acts as a cofactor in the 
initial reaction of insulin with the receptor sites of insulin-
sensitive cell membrane (Das, 1990). If the effect of 
chromium is associated with insulin action, it is probable 
that its beneficial effect might be as a result of its 
involvement in carbohydrate metabolism which is a 
source of energy. The same is true of manganese (Mg) 
which is known to play a fundamental role in the 
synthesis of glycoproteins, specially involved in bone 
formation. It is also known to be a component of pyruvate 
carboxylase and acts as a cofactor in the respiratory 
enzymes. These metabolic processes lead to energy 
production which is very much in demand in the sickle 
cell disease. Further discussions on these micronutrients 
will continue as we examine the other disease conditions 





In the past few years, malaria has attracted more 
attention with the establishment of several new initiatives 
such   as   the   Roll   Back   Malaria   Partnership,   partly  








because of increasing recognition that the malaria 
situation in-Saharan Africa has deteriorated due to many 
reasons which include political instability, poverty and 
poor infrastructure in the development of efficient health 
services. This situation is aggravated by the fact that 
malaria and HIV interact in several ways but drug 
resistance poses the greatest problem (Greenwood et al.,  
2005). Malaria deaths are estimated at 1.5 to 2.7 million a 
year, most of which are children under five years and 
pregnant women (WHO, 1998). 90% of these deaths 
occur in sub-Saharan Africa (Young et al., 2000). 
 
 
Micronutrients and Malaria management 
 
Zinc, vitamins A, E, carotenoids, vitamins B, C and folic 
acid have been reported to have modulatory effects on 
the pathogenesis of malaria. These micronutrients have 
been found to be deficient in acute Plasmodium 
falciparum infection and we shall consider their roles 
subsequently. Malaria and sickle cell disease originate 
from different causes but they share some common 
clinical presentations which include anemia, impaired 
growth and immune function as well as generation of 
reactive oxygen species. As we have done in the 
preceding discussions on sickle cell disease, we shall 
examine the use of micronutrients in the control of these 
metabolic changes associated with malaria. 
 
 
Iron and vitamin A in malaria-induced anemia 
  
It is well established that malaria causes anemia 
(Nwanyanwu et al., 1996). According to young et al. 
(2000), the consensus statement on the relationship 
between iron and malaria is that a concurrent 
implementation of iron supplementation and malaria 
control activities is the ideal (INACG, 1999). Some 
studies have shown that oral iron therapy enhanced 
haematological recovery of patients with falciparum 
malaria treated with sulphadoxine-primethamine (SP), it 
also tended to prolong their parasitemia (Young et al., 
2000). Another report indicates that malaria infection 
seriously worsens iron status and satisfactory improve-
ment cannot be achieved by iron supplementation unless 
the  underlying malaria is treated (Gera and Sachdev, 
2002; ACC/SCN, 1997). Also low serum iron levels inhibit 
replication of the malaria parasite and some earlier 
studies have shown an increase in malaria episodes after 
iron deficiency has been treated (Masawe et al., 1974). 
This seems to be a pointer to the fact that the relationship 
between iron supplementation and malaria is not yet 
understood. Nonetheless, it has been reported that 
vitamin A supplementation combined with iron supple-
mentation, is more effective in reducing anemia than iron 
supplementation alone (Angeles-Agdeppa,1997; Young 
et al., 2000; Crawley, 2003) and periodic high doses of 
vitamin A alone  can  improve  iron status  of a population 




Vitamins A, C and zinc in the control of impaired 
growth and immune function in malaria 
 
Vitamin A is necessary for normal immune function. Its 
deficiency is characterized by widespread immunological 
effects, including pathological alterations in mucosal 
surfaces, impaired antibody responses, changes in 
lymphocyte populations and altered T- and B-cell 
function, comprised function of neutrophils, macrophages 
and natural killer (NK) cells, altered immune responses 
and altered antibody responses (Semba, 1994, 1999). 
There is a widespread recognition of vitamin A 
deficiency and malaria as two widely distributed public 
health problems in the developing world. In sub-Saharan 
Africa, vitamin A deficiency and malaria coexist, each 
exacerbating the health consequencies of the other 
(Young et al., 2000). Though there is belief that there is 
association between vitamin A and malaria but the 
specific effects of vitamin A on malaria morbidity and 
mortality are not understood. Some studies have shown 
that vitamin A potentiates host resistance to malaria 
(Serghides and Kain, 2002). These workers observed 
that 9-cis-retinoic acid, a metabolite of vitamin A 
increased parasite clearance and reduced 
proinflammatory cytokinine responses to malaria parasite 
infection. Therefore, immunological effects can account 
for, at least, part of the mechanism by which vitamin A 
impacts positively on malaria management.  
The interaction between zinc and malaria is less well 
understood. In children with acute malaria infection, 
plasma zinc concentration has been found to be very low 
and inversely related to the acute phase protein, C-
reactive protein (CRP) (Duggen et al., 2005; Muller et al., 
2001). Rural African children who consume cereal or 
tuber-based diets which are low in animal products and 
high in phytic acid are likely to be vulnerable to zinc 
deficiency (Wise, 1995; Hambidge, 1997). Children 
appear to be more vulnerable to low zinc status, 
presumably, due to their high zinc requirements for 
growth and development (Gibson, 1994). Duggen et al. 
(2005) were of the opinion that in children whose age, 
diet, and/or nutritional status place at risk of zinc 
deficiency, those with low zinc levels should be 
supplemented with oral zinc and should be followed with 
clinical and/or biochemical response. They further 
suggested that when available, plasma zinc 
concentrations should be evaluated with concurrent 
measures of the acute phase response. Like vitamin A, 
zinc is known to be an immune modulating agent and is 
essential for normal immune function. It is known that 
zinc is important for cell-mediated immunity through 
neutrophils, macrophages and NK cells, and it affects the 
development of acquired immunity and antibody produc-










Vitamin C has been suggested to play a significant role 
in the pathogenesis of acute falciparum infection (Garba 
et al., 2002). These researchers reported that vitamin C 
enhanced the humoral and cellular immune  response to 
acute falciparum infection in male and female  adults. 
Their work provides evidence that adult with falciparum 
malaria mobilize their tissue store of ascorbate as part of 
their response to infection, hence the increase in the 
ascorbate level observed in these patients. Apparently, 
this observation is not consistent with association of 
malaria infection with depressed immunity in children 
where decreased plasma ascorbate level was observed. 
This was attributed to the immature nature of the immune 
system in children who must be provided with doses of 
ascorbic acid supplements to protect them from oxidant 
compounds released from the red cell rapture during 
falciparum malaria infection. 
Vitamin C has been shown in many studies to modulate 
a wide variety of cellular functions which include bone 
formation, folic acid metabolism, regulation of the 
respiratory cycle in the mitochondria and microsomes, 
enhancement of absorption of iron, formation and 
maturation of red blood cells and immune response 
mechanisms (Garba et al., 2002).   
 
 
Vitamins A, E and the carotenoids in the 
management of oxidative stress in malaria 
 
These micronutrients are well known to have antioxidant 
effects but not much work has been done in relation to 
their interaction with falciparum malaria infection. 
However, one study carried out in children with acute 
malaria infection in Kampala, Uganda, showed that the 
plasma level of these vitamins were depressed  at 
enrollment and increased by day 7 (Metzger et al., 2001). 
The study showed that higher plasma lycopene 
concentrations at enrollment were associated with 
clearance of parasitemia between enrollment and day 3. 
Their study suggested that the children with acute 





The classical approach to diabetic treatment depends on 
the cause of the disease, which could be due to insulin 
deficiency or dietary imbalance. If the cause is insulin 
deficiency, cure is via insulin therapy. This is very 
expensive for poor diabetics, many of whom dwell in rural 
communities in the developing countries. They often 
resort to the use of natural herbs which have not been 
scientifically evaluated. There is no doubt that our forests 
are replete with herbs with hypoglycemic properties but 
there is little that  can  be  said  about  them  scientifically,  
which is where the problem of the diabetics of the low 
socio-economic class lies. A casual survey of the 
incidence of diabetes in our communities revealed that it 
is widespread among the aging group. The question 
arises then as to the reason for its prevalence among the 
aged. The need arises then for research into the 
metabolic changes in glucose metabolism among the 
aging group. It is this curiousity that prompted this review, 
at least, as a starting point in looking into this problem. 
Micronutrients can regulate metabolism and gene 
expression and influence the development and 
progression of many chronic diseases of which diabetes 
is one (O’ Connell, 2001). Some of the micronutrients that 
have been associated with beneficial effects in diabetes 
include chromium, vanadium, nicotinamide, magnesium, 
vitamins E and B. Metabolic changes that occur in 
diabetes are complex and, if not properly controlled, are 
further complicated by secondary effects such as 
neuropathy, nephropathy, dyslipidemia cardiopathy and 
retinopathy, to mention but a few. But basically it is 
presented with glucose intolerance or insulin resistance 
which leads to hypoglycemia. Also diabetes-induced 
oxidative stress prevails. Subsequently, we shall examine 
how some of the identified micronutrients have influenced 
the management of these conditions. 
 
 
Chromium, vanadium and magnesium in the 
management of hypoglycemia in diabetes 
 
Chromium is required for normal glucose metabolism 
(O’Connell, 2001; Das, 1990, Anderson, 1998). 
According to Das (1990), chromium functions as a 
glucose tolerance factor but occurs in foods in varying 
different forms of which it is not yet clear in which form it 
is most effective. However, a particular form containing 
an organic moiety not fully characterized has been 
considered as the “glucose tolerance factor” (GTF). This 
particular form is much more effective than any other salt. 
Mammal are reported to have limited ability to synthesize 
GTF, therefore, it is important to investigate the 
occurrence of this form in foods instead of considering 
the total chromium content. For example, Das (1990) 
reported that chromium in beer is four times more 
effective in regulating glucose metabolism in rats than the 
chromium in lettuce, spinach or egg yolk. 
Experimental chromium deficiency leads to impaired 
glucose intolerance which improves upon the addition of 
chromium to the diet (O’Connell, 2001). Numerous 
studies have shown that chromium improves the 
glycemic state in different types of diabetes as well as 
various aspects of dyslipidemia (O’Connell, 2001). The 
severe impairment in glucose metabolism of children in 
many cases has been dramatically improved by giving 
oral dose of chromium chloride. In many cases, tissue 
chromium level has been found to fall with increasing age 
in both sexes, and  in women, with  each  pregnancy  and  








simultaneously their ability to metabolize sugar 
decreases and “maturity-onset-diabetes” develops. It is 
reported that in some of these cases, these conditions 
were improved by raising their chromium intake from 50 
to 200 µg/day (Das, 1990). 
Though it is well established that chromium has strong 
influence on glucose metabolism, its mechanism of action 
is not yet clearly understood. However, it is known to 
potentiate insulin action. According to O’Connell (2001), 
no chromium-containing enzyme has been discovered, 
and the biologically active form of chromium is still 
uncertain. But the actions of chromium have been 
attributed to an increase in the number of insulin 
receptors (Anderson, 1998), increased binding of insulin 
to the insulin receptor and increased activation of the 





Vanadium is not known to be an essential nutrient in man 
but is essential to ascidans (“sea squirts”) which can 
concentrate the element a million-fold from the sea water 
(Das, 1990). In animal models, vanadium has been 
shown to facilitate glucose uptake and metabolism, 
facilitate lipid and amino acid metabolism, improve 
thyroid function, enhance insulin sensitivity, and 
negatively affect bone and tooth decay in high doses. In 
humans, pharmacological doses alter lipid and glucose 
metabolism by enhancing glucose oxidation, glycogen 
synthesis, and hepatic glucose output. Vanadium acts 
primarily as an insulinmimetic agent, although enhanced 
insulin activity and increased insulin sensitivity have also 
been reported (O’Connell, 2001; Poucheret et al., 1998; 
Cam et al., 2000). 
Vanadium deficiency has not been documented in 
humans (Sarubin, 2000; Harland, 1994), but its deficiency 
has been reported to induce growth impairment in chicks 
and rats and it is specially required for the growth of 
feathers in chicks. Its deficiency induces impaired 
reproductive activity. In the absence of vanadium, tooth 
and bone metabolism are also affected (Das, 1990).  
The chemical nature of vanadium is similar to that of 
phosphorus and this seems to influence its biochemical 
actions (O’Connell, 2001). It may act as a phosphate 
analogue and has been shown to alter the rate of activity 
of a number of adenosine triphosphatases, phosphatases 





Magnesium is essential to all living organisms (Das, 
1990), and is an essential cofactor for more than 300 
enzymes (O’Connell, 2001). It is essential for all energy-
dependent transport systems, glycolysis, oxidative 
energy metabolism, biosynthetic reactions,  normal  bone  
metabolism, neuromuscular activity, electrolyte balance 
and cell membrane stabilization (De Valk, 1999). 
Magnesium is one of the more common micronutrient 
deficiencies in diabetes. Decreased magnesium levels 
and increased urinary magnesium losses have been 
documented in both Type I and Type II diabetic patients. 
Low dietary magnesium intake has been associated with 
increased incidence of Type II diabetes in some but not 
all studies (O’Connell, 2001). Magnesium deficiency has 
been associated with hypertention, insulin resistance, 
glucose intolerance, dyslipidemia, increased platelet 
aggregation, cardiovascular disease, complications of 
diabetes, and complications of pregnancy. But it is not 
clear whether poor magnesium status plays a casual role 
in these disorders or simply associated with them 
(O’Connell, 2001). 
The mechanism by which magnesium affects insulin 
resistance, hypertention, and cardiovascular disease are 
unknown. However, the widespread use of magnesium in 
normal metabolism of macronutrients, cellular transport 
systems, intracellular signaling systems, platelet 
aggregation, vascular smooth muscle tone and 
contractibility, electrolyte homeostasis, and 
phosphorylation and dephosphorylation reactions 




Nicotinamide helps to preserve B-cell function in 
diabetics 
 
Nicotinamide is one of the two forms of vitamin B3 
(niacin), the other form is nicotinic acid. The active forms 
are nicotinamide adenine dinucleotide (NAD) and the 
phosphate derivative (NADP). These coenzymes are 
essential for the function of hundreds of enzymes and 
normal carbohydrate, lipid and protein metabolism. 
Pharmacological doses of nicotinamide are being studied 
for their potential benefit in the prevention and treatment 
of diabetes (O’Connell). Animal studies suggest that 
nicotinamide acts by protecting pancreatic beta cells from 
autoimmune destruction by maintaining intracellular NAD 
levels and inhibiting the enzyme poly(ADP-ribose) 
polymerase (PARP), an enzyme involved in DNA repair. 
Excessive PARP induction results in depletion of 
cytoplasmic  NAD levels, induction of immunoregulatory 
genes, and cellular apoptosis (programmed cell death). 
Nicotinamide may additionally act as a weak antioxidant 
of nitric oxide radicals (O’Connell, 2001). 
The effects of nicotinamide supplementation have been 
studied in several trials focusing on the development and 
progression of Type I diabetes and one small trial in Type 
II diabetes but results have been inconsistent (O’Connell, 
2001). Nicotinamide appears to be most effective in 
newly diagnosed diabetes and in subjects with positive 
islet cell antibodies but not diabetes. People who develop 









nicotinamide treatment. Evidence emerging from different 
studies have offered more support for the idea that 




Vitamins E and B in the management of diabetes 
 
Vitamin E is an essential fat-soluble vitamin which 
functions primarily as an antioxidant. Low levels of 
vitamin E are associated with increased incidence of 
diabetes (Salonen et al., 1995). Some studies suggest 
that people with diabetes have decreased levels of 
antioxidants (Polidori et al., 2000). People with diabetes 
may have greater antioxidant requirement because of 
increased free radical production with hyperglycemia. 
Increased levels of oxidative stress markers have been 
documented in people with diabetes and improvement in 
glycemic control decreases markers of oxidative stress 
as does vitamin E supplementation (O’Connell, 2001). 
Vitamin E acts to neutralize free radical species produced 
during normal cellular metabolism, protecting cellular 
membranes and lipoproteins (LDL in particular) from 
oxidative damage. It also interacts with water-soluble 
antioxidants such as glutathione (O’Connell, 2001; Shils 
et al., 1999; Sarubin, 2000). It may play a role in 
preventing and treating common complications of 
diabetes, such as nephropathy, and neuropathy, by 
decreasing protein glycation, lipid oxidation, and inhibition 
of platelet adhesion and aggregation (O’Connell, 2001). 
O’Connel (2001) has documented reports from various 
clinical trials which investigated the effects of vitamin E 
on different aspects of diabetes which include diabetes 
prevention, insulin sensitivity, glycemic control, protein 
glycation and microvascular complications of diabetes. 
 
 
The B vitamins 
 
The vitamins, pyridoxine (vitamin B6), cobalamin (vitamin 
B12) and folate have been investigated for their effects 
on diabetic patients. Folate refers to a family of naturally 
occurring compounds. Folic acid is the synthetic form of 
the vitamin. Folate is an essential coenzyme for reactions 
involving the transfer of one carbon units in amino acid 
and nucleic acid synthesis. B6 acts as an essential 
cofactor for hundreds of enzymes and plays a role in 
glucose, lipid, amino acid metabolism and 
neurotransmitter synthesis. The active coenzyme form of 
the vitamin, pyridoxal 5’ phosphate, in muscle tissue is 
closely associated with glycogen phosphorylase. The 
amino acid, homocysteine, can be metabolized through 
transulfuration or remethylation. In the transulfuration 
pathway, homocysteine and serine combine to form 
cystathionine. This reaction is catalyzed by cystathione 
beta-synthetase and requires B6 as a coenzyme. In the 
remethylation pathway, vitamin B12 acts as  an  essential  
cofactor in a reaction in which homosysteine is converted 
to methionine by the methionine synthetase enzyme 
using folate as a methyl donor (O’Connell, 2001; Shils et 
al., 1999; Welch and Loscalizo, 1998). 
The three vitamins mentioned above are involved in 
homocysteine metabolism. Hyperhomocysteinemia 
(Hhcys) is positively correlated with coronary heart 
disease, cerebrovascular disease, and peripheral 
vascular disease (Welch and Losccalizo, 1998). It is not 
known whether the presence of Hhcys precedes or 
follows vascular disease (O’Connell, 2001). A recent 
prospective, population-based study found that Hhcys is 
a risk factor for overall mortality in Type II diabetic 
patients independent of other known risk factors. Hhcys 
was a twofold stronger risk factor for death in diabetic 
patients as compared to non-diabetic patients (O’Connell, 
2001). For each 5 µmol/l increment of homocysteine, risk 
of mortality rose by 17% in non-diabetic and 60% in 
diabetic subjects (Hoogeveen et al., 2000). 
In patients with diabetes and hyperhomocyteinemia, 
increased folate intake decreases and in some cases 
normalizes serum homocysteine levels (Aarsand and 
Carlsen, 1998; Baliga et al., 2000). In people with 
diabetes, there is an inverse relationship between serum 
folate and homocysteine levels in some but not all cases. 
the same is true for serum B12 and B6 is inversely 
correlated with post-methionine-load homocysteine levels 
(Busysschaert et al., 2000; Salardi et al., 2000; Stabler et 
al., 1999). O’Connell, (2001) advises that all patients with 
diabetes should be encouraged to consume adequate 
quantities of dietary folate, B12 and B6 and to modify 
factors such as alcohol intake and smoking, which 
increase homocysteine levels. 
 
 
DIETARY SOURCES OF MICRONUTRIENTS 
 
There is no doubt that in sub-Saharan Africa, ignorance, 
poverty and other social handicaps like political instability 
dispose a large population of our people to chronic 
energy deficiency and micronutrient malnutrition. This 
review is an attempt to stress the need to enlighten our 
people and to research into the invaluable benefits 
derivable in the micronutrients abundantly available in our 
natural resources.  
In the developed world, there is dramatic increase in 
the use of vitamins, minerals and other complementary 
nutrition-based therapies in disease management. 
O’Connell (2001) writes “Many health-care providers are 
also beginning to explore the use of these therapies in 
their practices. For those of us who work in conventional 
health care settings, it is a new venture. But for many of 
our patients who have been self-medicating with 
supplements, it is not….initially, the nutrition community 
focused on the roles micronutrients play in preventing 
deficiency diseases such as scurvy, pellagra, and rickets. 
As  our  understanding  of   nutritional   science   grew,   it  




                    Table 1. Dietary sources of micronutrients. 
 
Micronutrients Sources Remarks 
Zinc Beans, beef, brewer’s yeast, 
chicken heart, egg yolk, fish, 
herring, lamb, legumes, liver, 
meats, milk, oysters, peanuts, 
pork, poultry, pumpkin, seeds, 
seafood, soybeans, sunflower 
seeds, turkey, heat bran, wheat 
germ, whole grains, and yeast. 
 
Zinc is an animal protein 
compound, red meat has the 
highest concentration, but boiled 
chick pea has the highest in 
vegetable protein foods (Stallings, 
1999). Too much zinc causes 
anemia, suppressed immune 
system and impaired copper 
absorption (Anderson, 1988). 
Shellfish, particularly, oysters, are 
rich in zinc and copper. But more 
importantly, the minerals in 
shellfish are readily absorbable. 
The body uses them easily and 
efficiently. Zinc deficiency can 
occur in populations that consume 
staple diets rich in phytate which 
binds zinc tightly. 
Copper Crab, boiled beef, dry roasted 
cashews, sunflower seeds, whole 
wheat flour, banana, avocados, 
bakers yeast, beans, black 
pepper, garlic, grapes, green leafy 
vegetables, oysters, peanuts, 
seafood, lentils, liver, lobster, 
mushrooms, nuts, shrimp, 
soybeans, walnuts, wheat bran, 
and wheat germ. 
Too much copper produces 
damage to the brain, nervous 
system and kidneys. 
 
Chromium Apple peel, banana, beer, 
brewer’s yeast, brown sugar, 
butter, chicken, corn, dairy 
products, dried beans, eggs, fish 
liver, meat, mushrooms, oysters, 
potatoes with skin, seafood, 
shellfish, whole grains. 
Chromium is poorly absorbed 
(5%) bioavailability. Chromium 
occurs in foods to widely varying 
extent in different forms. The form 
containing an organic moiety, not 
yet fully characterized is known as 
the glucose tolerance factor 
(GTF), is the best absorbed. 
Magnesium Almonds, barley, brewer’s yeast, 
cocoa, cod, cotton seed, garlic, 
green leafy vegetables, herring, 
lima beans, meat, mackerel, 
millet, nuts, oats, peaches, peanut 
butter, peas, peanuts, seafood, 
shrimp, snails, soybeans, 
sunflower seeds, wheat, wheat 
bran, wheat germ, and  whole 
grains. 
 
Iron Almonds, avocados, beans, 
brewer’s yeast, broccoli, cashews, 
cocoa, dates, eggs, egg yolk, 
green leafy vegetables, spinach, 
heart, kidneys, legumes, lentils, 
liver, oysters, peaches, pears, 
potatoes, poultry, prunes, 
pumpkins, raisins, rice, seaweed, 
sesame seeds, soybeans, 
sunflower seeds, tongue, walnuts 
wheat bran, wheat germ, whole 
grains. 
The absorption of iron is 
influenced by what we eat with it. 
Vitamin C will double the amount 
of iron absorbed in the body. 
Including foods rich in vitamin C 
will increase iron intake. 
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Manganese Avocados, barley, beans, brown 
rice, chestnuts, cloves, coffee, 
egg yolk, ginger, grapevine, 
green vegetables, hazelnuts, 
legumes, nuts, oatmeal, peanuts, 
peas, pineapples, rice bran, rice 
polish, seaweed, seeds, spinach, 
walnuts, wheat bran, wheat germ, 
wholsse grain cereals. 
It is essential for the utilization of 
choline, thiamine, biotin and 
vitamins C and E. 
Selenium Barley, beer, butter, brewer’s 
yeast, broccoli, brown rice, 
cabbage, celery, cereals, chicken, 
cider vinegar, cinnamon, clams, 
crab, cucumbers, diary products, 
eggs, garlic, grains, green leafy 
vegetables, hibiscus, kidneys, 
lamb, liver, lobster, meats, milk, 
mushrooms, nutmeg, nuts, oats, 
onions, seafood, tuna, turnips, 
wheat bran, wheat germ, and 
wheat grains. 
 
Vitamin E Vegetable oils, margarines, wheat 
germ, seeds, and nuts. 
Vitamin E, has been shown to 
have anticoagulant properties. 
Those using medications and 
herbal supplements known to 
decrease blood clotting, e.g., 
warfarin, aspirin, garlic, and 
ginseng may be at risk for 
bleeding with high dose 
supplements (doses>800IU). 
Thiamine Whole grain, cereals, pock 
products, brewer’s          yeast, 
green peas, and other legumes, 
beef kidney, beef liver and 
sunflower seeds.                                                                                                     
Niacin liver, lean meats, poultry, 
peanut butter, beef kidney, 
legumes and salmon. 
To maintain adequate levels of 
any mineral or vitamin, it is best 
to consume a wide variety of food 
in reasonable amounts from all 
four food groups.
 Pyridoxin (B6) Whole grain cereals, liver, beef 
kidney, white   meat (chicken and 
fish), potatoes, avocados, 
bananas, egg yolk, and sunflower 
seeds. 
 
Cyanocobalamine(B12) Meat, liver, kidney, milk, Swiss 
cheese, salmon, and eggs. 
 
Fotate Wheat germ, beef, chicken heart, 
beef kidney, brewer’s yeast, 
mushrooms, oranges, and orange 
juice, broccoli, lima beans, 
bananas, strawberries, sunflower 






became clear that nutrients act in far broader ways. We 
now know that micro nutrients can regulate metabolism 
and gene expression and influence the development and 
progression of many chronic diseases. Eventually, we 
may be able to tailor nutritional recommendations to 
individual’s unique genetic make up, thus increasing the 
potential benefit and positive outcomes of medical 
nutrition therapy”. 
This long quotation emphasizes our point in this review. 
In  the  traditional  society,  many  of   the   diseases   that  








ravage a considerable percentage of our population were 
unknown because our ancients lived on natural 
resources. Here is a story of a sickle cell woman, in her 
sixties; we came across in the course of our research on 
natural products. She is not one of those who could not 
make it to 30 years of age. We asked her about her 
secret and she showed us some little plants in her garden 
which she has been using, particularly, a bean plant 
which is very familiar in the villages but which many 
families with sickle cell children do not know about. The 
plant, Cajanus cajan, has been reported by Iwu (1993) to 
have anti-sickling properties and a lot of research work is 
going on towards it development as an anti-sickling 
agent. 
Today, new thinking, even in the remotest villages, about 
catching on with “civilization”, as well as rural urban 
migration have led to change in lifestyle and taste. The 
trend is to eat refined rice, spaghetti, noodles etc, in 
place of our local foodstuff packed with health-enhancing 
micronutrients. We do not have to look hard in  
communities to notice the difference in the health 
disposition of the children of the enlightened families who 
understand the health implications of unbalanced diets 
and the children of the poor and ignorant who do not 
have the same understanding. The result in the later case 
is undernutrition/malnutrition and the consequent 
depression of immunity which disposes them to avoidable 
diseases. Common sources of the micronutrients 





There is need to intensify research to define the status of 
micronutrients not only in the diseases discussed in this 
review but also in other diseases prevalent in sub-
Saharan Africa. There is no doubt that a lot of questions 
remain to be answered with regards to the relationship 
between the micronutrients and the respective diseases 
as well as among the micronutrients themselves. Some 
diseases manifest in old age raising various questions: 
 
1. Is it micronutrient deficiency occurring in old age that 
causes metabolic changes which lead to a particular 
disease situation or is it the disease that leads to 
depletion of the micronutrients which further aggravate 
the situation? 
2. How would the different micronutrients interact with 
each other, with drugs and other nutrients?  
 
Furthermore, the micronutrient distribution in the foods in 
the different localities may vary from place to place 
because of soil differences. There is need to document 
this information because what is available now come 
mainly from the developed countries of the world where 
basic research into topics that are taken for granted are 
pursued with all seriousness. 
Finally, we hope that our medical practitioners will agree 
with their counterparts in the developed world, and 
embrace the concept that these essential nutrient 
components are abundant in our natural products and 
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